London: The deadly corona virus is stirred by the arrival of a new strain in the world which is reeling under the tightness of the epidemic. In view of this, BioNTech CEO Ugur Sahin has said that this virus will remain with us for at least a decade. At a virtual press conference this week, Sahin was asked questions related to the deadline of the virus. He was asked about the possibility of normal life again. He said, ‘We need a new definition of’ normal ‘. The virus will remain with us for the next 10 years. BioNTech’s vaccine was developed with the American Digestical Pfizer (Pfizer) and has been approved for use in more than 45 countries. These countries also include Britain and America.
Sahin further said that there is a possibility of adjusting the vaccine for the new strain of the virus that has arrived in Britain in a period of about 6 weeks. He cited technology and said, ‘The beauty of messenger technology is that we can directly start the engineering of vaccine which can completely copy this new mutation. We can provide a new vaccine in just 6 weeks. ‘ Sahin said that he was confident that the new strain of the Kovid-19 in Britain would not affect the capacity of the vaccine. Due to the new strain of Corona virus in Britain, drops of sweat have emerged on the forehead, including India. However, the result of this new strain has not been revealed yet. All U.K. air travelers to U.S. need negative Covid tests as mutant virus emerges, CDC says
Ever since this new variant of the virus has been identified in Britain, the country has recorded the highest number of deaths this week. Health Secretary Matt Hancock said that the second new variant is associated with tourists from South Africa and so far two cases have been reported. This week he said, ‘This new variant is more dangerous because it is quite contagious.’ On 19 December, Prime Minister Boris Johnson announced the new strain of Kovid-19 and said that it is 70 percent more infectious than before. Because of this, the Prime Minister has introduced restrictions in parts of London and England.
